Shopping Cart 0
Cart Subtotal
USD 0

Arno Therapeutics Inc (ARNI)-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Arno Therapeutics Inc (Arno) is a clinical stage biopharmaceutical company that develops products for the treatment of cancer, infectious diseases and other life threatening diseases. The company has exclusive worldwide rights for the development and commercialization of Onapristone (for the treatment of breast and endometrial cancer) with Invivis Pharmaceuticals, Inc.; AR-42 (for hematological malignancies and solid tumors); and AR-12, (for solid tumors and lymphoma) with the Ohio State University. These compounds are in clinical or preclinical stages of development. The company has agreements with pharmaceutical companies and research institutes to develop its product portfolio. Arno Therapeutics is headquartered in Flemington, New Jersey, the US.

Arno Therapeutics Inc (ARNI)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Arno Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Arno Therapeutics Inc, Medical Devices Deals, 2011 to YTD 2017 9

Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 12

Partnerships 12

Arno Therapeutics Enters into R&D Agreement with US Army Medical Research Institute of Infectious Diseases 12

Licensing Agreements 12

Arno Therapeutics Enters Into Licensing Agreement With University of Minnesota 12

Arno Therapeutics Enters into Licensing Agreement with Invivis Pharma for Onapristone 13

Equity Offering 14

Arno Therapeutics to Raise Funds through Public Offering of Shares 14

Arno Therapeutics Raises USD2.3 Million in First Tranche of Private Placement of Units 15

Arno Therapeutics Raises USD5.3 Million in Private Placement of Shares 17

Arno Therapeutic Raises USD5.3 Million in Private Placement of Shares 18

Arno Therapeutics Completes Private Placement Of Units For US$30.7 Million 19

Debt Offering 21

Arno Therapeutics Raises USD2 Million in Private Placement of 6% Notes Due 2016 21

Arno Therapeutics Completes Private Placement Of Debentures Due 2015 For Additional US$2 Million 21

Asset Transactions 22

Vivacitas Oncology Acquires Preclinical and Clinical Data Package from Arno Therapeutics 22

Arno Therapeutics Inc-Key Competitors 24

Key Employees 25

Locations And Subsidiaries 26

Head Office 26

Recent Developments 27

Financial Announcements 27

Nov 14, 2016: Arno Therapeutics Reports Third Quarter 2016 Financial and Business Update 27

Aug 22, 2016: Arno Therapeutics Reports Second Quarter 2016 Financial and Business Update 28

May 16, 2016: Arno Therapeutics Reports First Quarter 2016 Financial and Business Update 29

Mar 30, 2016: Arno Therapeutics Reports Fourth Quarter and Full Year 2015 Financial Results and Business Update 30

Clinical Trials 31

Apr 19, 2016: Arno Therapeutics to Focus Clinical Developmental Activities on Advanced Prostate Cancer in First-of-its-Kind Phase II Study of Onapristone in Combination with ZYTIGA 31

Mar 21, 2016: Arno Therapeutics Advances Phase I/II Trial Evaluating Onapristone in Prostate Cancer to Phase II 32

Appendix 33

Methodology 33

About GlobalData 33

Contact Us 33

Disclaimer 33


List Of Figure

List of Figures

Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6

Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Arno Therapeutics Inc, Medical Devices Deals, 2011 to YTD 2017 9


List Of Table

List of Tables

Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 1

Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Arno Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Arno Therapeutics Inc, Deals By Therapy Area, 2011 to YTD 2017 8

Arno Therapeutics Inc, Medical Devices Deals, 2011 to YTD 2017 9

Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Arno Therapeutics Enters into R&D Agreement with US Army Medical Research Institute of Infectious Diseases 12

Arno Therapeutics Enters Into Licensing Agreement With University of Minnesota 12

Arno Therapeutics Enters into Licensing Agreement with Invivis Pharma for Onapristone 13

Arno Therapeutics to Raise Funds through Public Offering of Shares 14

Arno Therapeutics Raises USD2.3 Million in First Tranche of Private Placement of Units 15

Arno Therapeutics Raises USD5.3 Million in Private Placement of Shares 17

Arno Therapeutic Raises USD5.3 Million in Private Placement of Shares 18

Arno Therapeutics Completes Private Placement Of Units For US$30.7 Million 19

Arno Therapeutics Raises USD2 Million in Private Placement of 6% Notes Due 2016 21

Arno Therapeutics Completes Private Placement Of Debentures Due 2015 For Additional US$2 Million 21

Vivacitas Oncology Acquires Preclinical and Clinical Data Package from Arno Therapeutics 22

Arno Therapeutics Inc, Key Competitors 24

Arno Therapeutics Inc, Key Employees 25

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Arno Therapeutics Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Arno Therapeutics Inc (Arno) is a clinical stage biopharmaceutical company that develops products for the treatment of cancer, infectious diseases and other life threatening diseases. The company has exclusive worldwide rights for the development and commercialization of Onapristone (for the treatment of breast and endometrial cancer) with Invivis Pharmaceuticals, Inc.; AR-42 (for hematological malignancies and solid tumors); and AR-12, (for solid tumors and lymphoma) with the Ohio State University. These compounds are in clinical or preclinical stages of development. The company has agreements with pharmaceutical companies and research institutes to develop its product portfolio. Arno Therapeutics is headquartered in Flemington, New Jersey, the US.

Arno Therapeutics Inc (ARNI)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Arno Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Arno Therapeutics Inc, Medical Devices Deals, 2011 to YTD 2017 9

Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 12

Partnerships 12

Arno Therapeutics Enters into R&D Agreement with US Army Medical Research Institute of Infectious Diseases 12

Licensing Agreements 12

Arno Therapeutics Enters Into Licensing Agreement With University of Minnesota 12

Arno Therapeutics Enters into Licensing Agreement with Invivis Pharma for Onapristone 13

Equity Offering 14

Arno Therapeutics to Raise Funds through Public Offering of Shares 14

Arno Therapeutics Raises USD2.3 Million in First Tranche of Private Placement of Units 15

Arno Therapeutics Raises USD5.3 Million in Private Placement of Shares 17

Arno Therapeutic Raises USD5.3 Million in Private Placement of Shares 18

Arno Therapeutics Completes Private Placement Of Units For US$30.7 Million 19

Debt Offering 21

Arno Therapeutics Raises USD2 Million in Private Placement of 6% Notes Due 2016 21

Arno Therapeutics Completes Private Placement Of Debentures Due 2015 For Additional US$2 Million 21

Asset Transactions 22

Vivacitas Oncology Acquires Preclinical and Clinical Data Package from Arno Therapeutics 22

Arno Therapeutics Inc-Key Competitors 24

Key Employees 25

Locations And Subsidiaries 26

Head Office 26

Recent Developments 27

Financial Announcements 27

Nov 14, 2016: Arno Therapeutics Reports Third Quarter 2016 Financial and Business Update 27

Aug 22, 2016: Arno Therapeutics Reports Second Quarter 2016 Financial and Business Update 28

May 16, 2016: Arno Therapeutics Reports First Quarter 2016 Financial and Business Update 29

Mar 30, 2016: Arno Therapeutics Reports Fourth Quarter and Full Year 2015 Financial Results and Business Update 30

Clinical Trials 31

Apr 19, 2016: Arno Therapeutics to Focus Clinical Developmental Activities on Advanced Prostate Cancer in First-of-its-Kind Phase II Study of Onapristone in Combination with ZYTIGA 31

Mar 21, 2016: Arno Therapeutics Advances Phase I/II Trial Evaluating Onapristone in Prostate Cancer to Phase II 32

Appendix 33

Methodology 33

About GlobalData 33

Contact Us 33

Disclaimer 33


List Of Figure

List of Figures

Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6

Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Arno Therapeutics Inc, Medical Devices Deals, 2011 to YTD 2017 9


List Of Table

List of Tables

Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 1

Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Arno Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Arno Therapeutics Inc, Deals By Therapy Area, 2011 to YTD 2017 8

Arno Therapeutics Inc, Medical Devices Deals, 2011 to YTD 2017 9

Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Arno Therapeutics Enters into R&D Agreement with US Army Medical Research Institute of Infectious Diseases 12

Arno Therapeutics Enters Into Licensing Agreement With University of Minnesota 12

Arno Therapeutics Enters into Licensing Agreement with Invivis Pharma for Onapristone 13

Arno Therapeutics to Raise Funds through Public Offering of Shares 14

Arno Therapeutics Raises USD2.3 Million in First Tranche of Private Placement of Units 15

Arno Therapeutics Raises USD5.3 Million in Private Placement of Shares 17

Arno Therapeutic Raises USD5.3 Million in Private Placement of Shares 18

Arno Therapeutics Completes Private Placement Of Units For US$30.7 Million 19

Arno Therapeutics Raises USD2 Million in Private Placement of 6% Notes Due 2016 21

Arno Therapeutics Completes Private Placement Of Debentures Due 2015 For Additional US$2 Million 21

Vivacitas Oncology Acquires Preclinical and Clinical Data Package from Arno Therapeutics 22

Arno Therapeutics Inc, Key Competitors 24

Arno Therapeutics Inc, Key Employees 25

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Arno Therapeutics Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.